| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.42 | 1e-14 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.3 | 6e-14 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.29 | 7e-13 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.28 | 6e-11 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.41 | 1e-09 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.41 | 8e-09 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-08 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-07 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.37 | 6e-07 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |